Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Work In Process (2018 - 2019)

Historic Work In Process for Niagen Bioscience (NAGE) over the last 2 years, with Q4 2019 value amounting to $4.7 million.

  • Niagen Bioscience's Work In Process rose 6675.02% to $4.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.7 million, marking a year-over-year increase of 6675.02%. This contributed to the annual value of $4.7 million for FY2019, which is 6675.02% up from last year.
  • Per Niagen Bioscience's latest filing, its Work In Process stood at $4.7 million for Q4 2019, which was up 6675.02% from $2.8 million recorded in Q4 2018.
  • In the past 5 years, Niagen Bioscience's Work In Process ranged from a high of $4.7 million in Q4 2019 and a low of $2.8 million during Q4 2018